Demo

10 Articles Matching "hadlima"

Rinvoq vs. Hadlima

Sep 04, 2019 , RxList
Rinvoq (upadacitinib) and Hadlima (adalimumab-bwwd) are used to treat adults with moderately to severely active rheumatoid arthritis....
Read more

Rituxan vs. Hadlima

Aug 20, 2019 , RxList
Rituxan (rituximab) and Hadlima (adalimumab-bwwd) are used to treat rheumatoid arthritis...
Read more

Cimzia vs. Hadlima

Aug 17, 2019 , RxList
Cimzia (certolizumab pegol) and Hadlima (adalimumab-bwwd) are tumor necrosis factor (TNF) blockers used to treat Crohn's disease...
Read more

Olumiant vs. Hadlima

Aug 17, 2019 , RxList
Olumiant (baricitinib) and Hadlima (adalimumab-bwwd) are used to treat rheumatoid arthritis...
Read more

Enbrel vs. Hadlima

Aug 17, 2019 , RxList
Enbrel (etanercept) and Hadlima (adalimumab-bwwd) are tumor necrosis factor (TNF) blockers used to treat rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and plaque psoriasis (Ps)....
Read more
Banner Health Children

Orencia vs. Hadlima

Aug 17, 2019 , RxList
Orencia (abatacept) and Hadlima (adalimumab-bwwd) are indicated for treatment of rheumatoid arthritis...
Read more

Humira vs. Hadlima

Aug 17, 2019 , RxList
Humira (adalimumab) and Hadlima (adalimumab-bwwd) are tumor necrosis factor (TNF) blockers indicated for treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps)....
Read more

Actemra vs. Hadlima

Aug 17, 2019 , RxList
Actemra (tocilizumab) and Hadlima (adalimumab-bwwd) are used to treat rheumatoid arthritis...
Read more

Eticovo vs. Hadlima

Aug 17, 2019 , RxList
Eticovo (etanercept-ykro) and Hadlima (adalimumab-bwwd) are tumor necrosis factor (TNF) blockers used to treat rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and plaque psoriasis (Ps)....
Read more

Samsung Bioepis Humira biosimilar wins FDA approval

Jul 25, 2019 , Reuters
(This story corrects to show that Hadlima belongs to Samsung Bioepis not Merck & Co Inc, which is commercializing the drug in the United States)...
Read more